Elite athlete testing now in Tulsa! VO2 Max assessments at Ascension St. John measure your heart's true potential. 30 minutes ...

Deepak L. Bhatt, MD, MPH: Let me turn now to Dr Navar to discuss what I think is an important part of the discussion. She’s done a lot of work on this. How do we actually estimate patients’ risk for ...

Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...

The field of retinal imaging has long provided a unique, non-invasive window to systemic vascular health, with microvascular ...

CMS released proposals to update cardiovascular disease risk assessment and risk management services. The organization proposed coding and payment for an atherosclerotic cardiovascular disease risk ...

Please provide your email address to receive an email when new articles are posted on . Conducting a post hoc analysis of the Canagliflozin cardiovascular Assessment Study Program, researchers ...

Please provide your email address to receive an email when new articles are posted on . Peripheral artery disease, or PAD, is a leading cause of lower extremity amputations in the U.S. Health care use ...

The score is commonly calculated in primary care ...

The effect of Invokana on CV risk was evaluated in the CANVAS (CANagliflozin cardioVascular Assessment Study) Program in >10,000 adults with T2D who had established CV disease or were at risk for CV ...

Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality worldwide. The Global Burden of Disease (GBD) 2023 study states that a total ...